Tumor‐associated macrophages (TAMs), thought to contribute to the progression of cancer through immunosuppression and matrix remodeling, have enhanced levels of CD206 (Choi et al., 2017; Martinezpomares, 2001; Nielsen et al., 2020). Here, MRC1 is linked to cancer.